The groundbreaking approach of the medication represents a significant development in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide338823.dailyblogzz.com/42497749/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment